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The private healthcare sector in South Africa (SA) forms part of 
the country’s two-tiered healthcare model (private and public). 
The private healthcare sector serves ~20% of the population and 
consumes ~50% of total healthcare expenditure. In comparison, the 
public healthcare sector serves ~80% of the population and utilises 
~48% of total healthcare expenditure.[1] The majority of the spending 
(81%) in private healthcare is financed through the 82 registered 
medical aid schemes’ prepaid plans and 14% is paid out of pocket.[1] 
Medical aid schemes are categorised into open (n=22) and restricted 
(n=60) schemes.[2] Open medical aid schemes are open to all South 
Africans, while restricted schemes are restricted to groups such as 
employees of an organisation.[3] In 2016/17, the 22 open medical aid 
schemes had 4 953 180 beneficiaries (this included both principal 
members and their dependants), while the 60 restricted medical aid 
schemes had 3 924 901 beneficiaries.[2]
The key role of medical aid schemes in SA, under the Medical 
Schemes Act (MSA) (Act No. 131 of 1998),[4] is to pay the healthcare 
expenses of their beneficiaries. This role is based on the agreement 
that medical aid scheme members pay monthly contributions towards 
specific scheme benefit plans, which then guarantees payment of 
their acquired healthcare expenses.[3] Prescribed Minimum Benefits 
(PMBs) in SA are a set of benefits the purpose of which is to ensure 
that all members of medical aid schemes have access to certain 
minimum health services, regardless of their benefit options.[5] 
PMBs were introduced under the MSA as a policy tool to define the 
minimum acceptable levels of benefits that medical aid schemes are 
required to cover.[6] The first goal of defining PMBs was to prevent 
instances where beneficiaries were deprived of their medical aid 
scheme cover when sick, and the subsequent use of public sector 
facilities. The second goal was to enhance efficiency in the allocation 
of resources between the private and public sectors.[6]
All 82 medical aid schemes are legally obliged to pay costs related 
to the specified diagnosis, treatment and care of PMBs.[5] PMBs are 
classified into three groups: (i) any emergency medical condition; 
(ii)  a limited set of 270 medical conditions; and (iii) 25 chronic 
conditions.[5] The role of the Council for Medical Schemes (CMS) is 
to ensure that medical aid schemes abide by their legal obligations 
according to the MSA.[4] Even though medical aid schemes are liable 
to pay for all three groups of PMBs, members and healthcare providers 
are required to abide by the schemes’ protocols and guidelines. 
These guidelines include the schemes’ diagnosis, treatment and care 
protocols for PMBs and using schemes’ designated service providers 
(DSPs).[7] DSPs are healthcare providers (medical doctors, hospitals, 
etc.) that medical schemes prefer their members to use when they 
need diagnosis, treatment or care for PMBs.[7] The contracts with 
DSPs include agreed-upon standard fees for PMBs. When a member 
breaches these guidelines, medical aid schemes are exonerated 
from paying. Appeals for PMB conditions therefore arise when 
schemes refuse to pay in full or insist on co-payments for diagnosis, 
treatment, management and care of PMBs. Some of the reasons 
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linked to this refusal of payment include: 
(i) members voluntarily using non-DSPs 
for health services; (ii) members obtaining 
treatment that forms part of the scheme’s 
exclusion or is not part of the treatment 
protocol for a specific PMB; (iii) members 
opting for treatment that has co-payment 
requirements; and (iv) members being in 
arrears in terms of their monthly membership 
contributions. [5] Both the medical aid 
schemes and the PMBs are regulated under 
the MSA. [4,6] The MSA designates the CMS as 
the responsible body to protect the interests of 
members of medical aid schemes.[8] Members 
of medical aid schemes therefore have a right 
to lodge complaints with the CMS in relation 
to PMBs if payments have been wrongly 
denied. The medical aid schemes’ complaint 
and appeal process in SA is divided into five 
levels: (i) the internal medical aid scheme 
dispute committee; (ii) the CMS Registrar; 
(iii)  the CMS Appeal Committee; (iv) the 
CMS Appeal Board (at a cost of ZAR2 800 by 
the appellant); and (v) the High Court.[8]
All stakeholders (including medical aid 
schemes, members and healthcare providers) 
have a right to appeal the rulings and judg-
ments. In 2009, the CMS noted with concern 
that there had been a dramatic increase from 
9.3% to 25.4% in the number of complaints 
in relation to PMBs.[9] In an effort to identify 
issues leading to this increase, the CMS 
undertook an evaluation, the findings of which 
revealed high non-compliance by medical 
aid schemes in terms of payment for PMBs. 
Medical aid schemes also confirmed their non-
compliance.[9] As part of the inter vention a task 
team was formed, and it developed a code of 
conduct for ensuring full compliance with the 
provisions of the PMBs. A decrease in PMB 
complaints was then seen during the period 
2009/10.[9] However, despite this intervention, 
complaints in respect of PMBs increased to 
40% by 2011/12.[10] While the CMS publishes 
summaries of the PMB complaints patterns in 
its annual reports, there are no published data 
on the patterns of PMB appeals in SA.[2]
Understanding the pattern of PMB appeals 
in the SA private health sector could benefit 
both members and medical aid schemes and 
could contribute to the reduction of wrongful 
denials of payments regarding PMBs.
Objectives
To determine and describe the pattern of 
PMB appeals in SA from 1 January 2006 to 
31 December 2016.
Methods
Study design and data collection
This was a descriptive cross-sectional study. 
Secondary data were obtained from the CMS 
Judgments on Appeals database between 
2006 and 2016. All reports were retrieved.
The following data were extracted: 
(i)  the basis of the appeal; (ii) whether the 
condition was a PMB; (iii) the level of the 
appeal process (CMS Appeal Committee 
or Appeal Board or High Court); (iv) the 
final judgment (upheld or overturned or no 
judgment); (v) appellants and respondents; 
(vi) the type of medical aid scheme (open 
or restricted); and (vii) the year in which 
the judgment was made. The CMS’s lists 
of PMBs and the 25 chronic medical 
conditions were consulted to confirm 
whether conditions were PMBs. Also, the 
CMS’s list of registered medical aid schemes 
was used to categorise medical schemes as 
either open or restricted.
Data analysis
The collected data were entered onto an Excel 
spreadsheet (2016, version 16.0.4229.1002; 
Microsoft, USA) and coded. Descriptive 
statistics (percentages and frequencies) were 
used to summarise categorical data, while 
medians and interquartile ranges (IQRs) 
were used for numerical data. Stata version 
14 software (StataCorp, USA) was used for 
analysis.
Ethical considerations
Permission to utilise the data was received 
from the CMS’s Chief Executive Officer 
and ethics approval was granted by the 
University of Pretoria Faculty of Health 
Sciences Research Ethics Committee (ref. 
no. 551/2017).
Results
Of the 340 eligible appeals on the CMS 
database, a total of 123 (36.2%) were PMB 
appeals and therefore included in the study. 
Appeals that did not meet the inclusion 
criteria were excluded (Fig. 1).
PMB appeals included
n=123
Appeals retrieved from the CMS Judgments 
on Appeals database
N=370
Duplicate appeals excluded
n=23
Appeals with missing information excluded
n=7
Eligible appeals
n=340
Legal/governance category appeals
n=110
Administrative category appeals
n=36
Clinical category appeals
n=194
Non-PMB appeals excluded 
n=71
Fig. 1. Selection process of PMB appeals for 1 January 2006 - 31 December 2016. (PMB = Prescribed 
Minimum Benefits; CMS = Council for Medical Schemes.)
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The median number of PMB appeals per year was 11 (IQR 9 - 27). 
The number of PMB appeals throughout the 11-year period of 
analysis is shown in Table 1.
Of the 123 appeals, 50.4% (62/123) were by medical aid schemes 
appealing their liability to pay for the PMBs, and of these 69.4% 
(43/62) were found in favour of members and 30.6% (19/62) in 
favour of medical aid schemes. The remainder of the PMB appeals 
(49.6%, 61/123) were by members (and one healthcare provider) 
appealing that medical aid schemes were liable to pay for PMBs. Of 
these appeals, 80.3% (49/61) were found in favour of the medical aid 
schemes. Only 11.5% (7/61) were overturned to favour members, and 
‘no judgments’ were made for 8.2% (5/61) of these appeals. The five 
main reasons that medical aid schemes cited for refusing payment 
were: (i) treatments used by members were scheme exclusions or 
not part of the treatment protocol for a PMB condition (41.0%); 
(ii)  members used non-DSPs to obtain treatment and care for PMBs 
(14.8%); (iii) treatment chosen by members required co-payments 
(6.7%); (iv) depleted benefit funds (5.0%); and (v) off-label use of 
treatment (i.e. not complying with the instructions for administering 
the drugs/medication) by healthcare providers in treating members 
(3.3%).
A range of PMB conditions were identified, and the top 10 
most commonly appealed conditions are listed in Table 2. The 
top three conditions included in the appeals were cancer (18.0%), 
emergency conditions (8.1%) and pregnancy (6.5%). Four conditions 
constituted the fewest appeals in this list: heart conditions, fractures, 
hyperlipidaemia and respiratory conditions (all 3.3%).
More than half (60.0%, 6/10) of the 10 emergency conditions 
appealed were disputes about whether they were genuine emergencies 
for members to have involuntarily acquired non-DSPs’ services. Two 
of these emergencies were appeals where healthcare providers had 
claimed a special fee (termed the Modifier 0019 fee) for premature 
baby emergencies. Half of the judgments on these appeals found 
in favour of the members and half were in favour of medical aid 
schemes.
There were three types of appellants and four types of respondents 
identified in the PMB appeals over the period of analysis. Healthcare 
providers played a minor role with regard to being either an appellant 
or a respondent (Table 3).
Overall, in terms of type of schemes the appeals were linked to, 
open medical aid schemes accounted for 82.1% (101/123) of the PMB 
appeals, while restricted medical aid schemes accounted for 17.9% 
(22/123). The majority (92.7%, 114/123) of PMB appeals did not 
progress beyond the first level of appeal (the Appeal Committee). No 
PMB appeals were recorded as progressing to the High Court.
Discussion
This study is the first to review appeals on PMBs in SA beyond a 
single CMS reporting cycle. Over the period of analysis, no clear 
pattern was found in terms of the numbers of appeals increasing or 
decreasing. The number of PMB appeals was lowest in 2009, and this 
coincided with the year that the Registrar of the CMS implemented 
a code of conduct for PMB regulation compliance by medical aid 
schemes.[9] This code of conduct was a result of a notable increase in 
the number of PMB complaints and confirmed non-compliance with 
PMB regulation by medical aid schemes prior to this date.[9] Despite 
implementation of this intervention, after 2009 the number of PMB 
appeals fluctuated over the period of analysis, with 2012 recording 
the highest number to date. The year 2013 had the second-lowest 
number of PMB appeals, and this corresponded with the Registrar’s 
second intervention.[11] The complaints lodging system was revised 
and healthcare providers were instructed to first exhaust all internal 
medical aid scheme resolution processes before approaching the 
CMS.[11] This intervention may explain the reduced number of 
complaints referred to the CMS in 2013 and 2014.[11]
However, by 2015 and 2016 there was a rise in PMB appeals 
referred to the CMS. Cancers of various types and emergency 
conditions constituted a large proportion of PMB conditions that 
members appealed and medical aid schemes contested paying. This 
finding differs from what was reported in the USA, where mental 
health conditions were the most rejected claims for payment by health 
insurers.[12] Both of these PMB categories (cancers and emergency 
conditions) are potentially life-threatening if not treated promptly, 
and cancers may require long-term and costly treatment. In terms of 
emergency conditions, the criteria used by medical aid schemes in 
deciding whether a condition was a real emergency seemed to be the 
main area of contention. The schemes’ varying interpretations of and 
Table 1. Annual numbers of published PMB appeals (N=123)
Year of judgment Frequency, n (%)
2006 3 (2.4)
2007 3 (2.4)
2008 8 (6.5)
2009 2 (1.6)
2010 15 (12.0)
2011 16 (13.0)
2012 28 (23.0)
2013 3 (2.4)
2014 7 (6.0)
2015 15 (12.0)
2016 23 (18.7)
PMB = Prescribed Minimum Benefits.
Table 2. Top 10 PMB conditions appealed (N=123)
Condition Frequency, n (%)
Cancer 22 (18.0)
Emergency conditions 10 (8.1)
Pregnancy 8 (6.5)
Crohn’s disease 6 (5.0)
Leukaemia 6 (5.0)
Hypertension 5 (4.1)
Heart conditions 4 (3.3)
Fractures 4 (3.3)
Hyperlipidaemia 4 (3.3)
Respiratory difficulties 4 (3.3)
PMB = Prescribed Minimum Benefits.
Table 3. Appellants and respondents on PMB appeals (N=123)
Frequency, n (%)
Appellants
Medical aid schemes 63 (51.0)
Members 59 (48.0)
Healthcare providers 1 (1.0)
Respondents
Medical aid schemes 58 (47.2)
Members 57 (46.3)
Healthcare providers 4 (3.3)
CMS 4 (3.3)
PMB = Prescribed Minimum Benefits; CMS = Council for Medical Schemes.
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conclusions regarding an emergency condition v. an urgent medical 
condition are a challenge for members. The findings from this study 
appear to support the US study, which showed that in the denial of 
payments, schemes’ interpretations of their guidelines sometimes 
vary.[12] The CMS PMB list defines an emergency condition as 
a sudden health condition in need of immediate treatment, but 
schemes appear to interpret this definition in a manner that favours 
avoidance of their paying.[5]
Half of the judgments on emergency conditions favoured members 
and half favoured schemes, further highlighting this contention and 
confusion. Unfortunately for members, when in their perspective a 
medical condition becomes an emergency they are likely to visit the 
nearest healthcare provider without confirming whether this is a DSP. 
The main priority for members in an emergency is to access medical 
care as soon as possible, before further and/or more permanent 
damage is sustained. This reasoning supports the CMS’s justification 
for why emergencies need prompt treatment.[5] In addition, the 
insurance afforded during emergencies is likely to be one of the 
reasons why people join medical aid schemes. Payment by medical 
aid schemes in such cases is therefore crucial to avoid out-of-pocket 
payment by members.
In the instances where members appealed, medical aid schemes 
were confirmed as liable to pay for the members’ PMB-related costs 
in the majority of the PMB appeals. The judgments on these appeals 
were not surprising, because refusals to pay for legitimate PMB 
claims strengthen the perception that schemes use claim denials as 
a way to save money. Of concern, however, is that it is not known 
how many legitimate PMB claims are rejected without members 
appealing. These study findings and concerns are corroborated by 
two studies in the USA which showed that medical aid schemes reject 
members’ legitimate medical claims purely to save money, and that 
most members do not appeal rejections of their medical claims.[11,13] 
One of these two studies found that only 7% of members appealed 
beyond the first level of appeal, while in the second study, ~4% of the 
complaints were appealed higher than the first level.[12,13]
Medical aid schemes were largely successful in their own appeals. 
Overall, members were less successful, as the majority of the claims 
were judged in favour of the medical aid schemes.
While medical aid schemes are liable by law to pay for PMBs, 
the responsibility also lies with members and healthcare providers 
to follow the schemes’ rules and guidelines in terms of diagnosis, 
treatment and care for PMBs.[5] A large proportion of members who 
appealed were found to be at fault. Most commonly the members had 
used non-DSPs to provide healthcare, or their healthcare providers 
administered PMB treatments that schemes were not liable to pay for, 
so that members were liable for the co-payment. In these instances, 
medical aid schemes are within the law to refuse to pay in full or to 
pay only a portion of a claim. As a result, members face a financial 
burden, as they have to make out-of-pocket payments. The use of 
non-DSPs exacerbates the problem, as these healthcare providers may 
charge substantially more than the schemes’ DSP rates.[7] Such non-
compliance could be due to medical aid schemes not communicating 
these processes properly; alternatively, members and healthcare 
providers may not be familiarising themselves with the processes.
The Appeal Committee of the CMS reviewed the largest proportion 
of PMB appeals, with very few reviewed by the CMS Appeal Board 
and none reaching High Court level. The escalation process of appeals 
in SA is similar to that in the USA, where an appeal can potentially 
be appealed from level one all the way up to level five, with level 
five being the Court for both countries.[12,13] The Appeal Committee, 
which is at level three of the SA appeal process, corroborates the US 
study findings that members escalate their appeals up to level two 
and three because judgments are normally not in their favour at level 
one.[12] The finding that only a few of the appeals were at Appeal 
Board level was not unexpected, because of the cost associated with 
referring cases to the Appeal Board.[8] Furthermore, as payment is 
the main area of contention in PMB appeals, additional costs are 
likely to prevent members from appealing further than the Appeal 
Committee. The additional costs and time needed for the higher 
levels of the appeal process (Appeal Board and High Court) are likely 
to affect members more than medical aid schemes or healthcare 
providers. The negative implication of the appeal-related costs is 
that even if members are unsatisfied with an Appeal Committee 
judgment, they may have no choice but to accept it.
No obvious difference was found between the medical aid schemes 
and members in their roles as appellants. Members are justified 
in appealing PMB payments in view of the rising out-of-pocket 
payments that have resulted from SA’s unsustainable healthcare 
financing system and that contribute to the financial burden of 
households.[14] Furthermore, as PMBs include chronic conditions, 
denial of payment could have an effect on life-threatening illnesses, 
which in turn is a motivation for members to appeal.[5] The right 
to appeal does not necessarily result in an actual appeal.[9] In SA it 
is difficult to ascertain how many members could potentially have 
appealed but did not do so over the 11-year period analysed. This lack 
of information is a challenge, because it is possible that there were 
potentially more legitimate PMB appeals that members ultimately 
paid out of pocket instead of appealing.
Few of the PMB appeals were linked to restricted medical 
aid schemes, despite the predominance of these schemes.[2] One 
explana tion could be the number of beneficiaries in open schemes 
(N=4  953  180) as opposed to restricted schemes (N=3 924  901).[2] 
Owing to their small number of beneficiaries per scheme (average of 
65 415 beneficiaries per scheme), it is possible that the 60 restricted 
medical aid schemes communicate more effectively with their 
members. In comparison, the 22 open medical aid schemes average 
225 144 beneficiaries per scheme. These differences in terms of 
numbers per scheme could be a factor contributing to the number 
of PMB appeals. Other possible explanations may be that restricted 
medical aid schemes have more effective PMB internal dispute 
resolution processes, or poor knowledge of the ‘outside’ appeal 
process on the part of members of the restricted medical aid schemes. 
This finding highlights a need for future research to understand why 
restricted medical aid schemes have fewer PMB appeals, taking into 
consideration the differences in the number of beneficiaries.
Study strengths and limitations
The strength of the present study is the 11 years’ worth of data that 
were available. The study did not take into consideration the size (i.e. 
number of beneficiaries) of the two types of medical aid schemes in 
the analysis. Also, based on the low number of appeals compared 
with the number of beneficiaries, annual rates were not calculated 
and only the annual actual numbers were analysed. The study also 
did not take into consideration appeals that were appealed more than 
once, as the CMS does not upload repeat appeals to the Judgments 
on Appeals database.
Finally, the use of secondary data is a limitation because the data 
were originally collected for a different objective to what they were 
used for in this analysis.
Conclusions
The CMS’s interventions to reduce the number of appeals have 
been effective but short-lived. The actual extent of the problem is 
masked, as it is likely that not all members who have a rejected PMB 
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claim appeal the decision. While the overall numbers of appeals are 
small in relation to the size of medical aid scheme membership, the 
consequences to individuals are substantial. Research is needed to 
understand the measures required to prevent conflict with regard 
to the various types of cancers and emergency conditions that 
constituted one-quarter of all PMB appeals. Medical schemes should 
revise their guidelines, policies and criteria for payment of these two 
services and improve their communication with healthcare providers 
and members.
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